Life sciences
M&A surged, with deal value increasing 123% and volume rising 109%, driven by growing demand for integrated diagnostics, life sciences tools, specialized care infrastructure and scalable manufacturing capabilities. Buyers prioritized pipeline expansion and therapeutic diversification, targeting differentiated late-stage assets and novel treatment platforms.
Aerospace and defense, mobility
M&A accelerated, with deal value rising 15% and volume increasing 94%, indicating that growth was driven primarily by a larger number of smaller transactions. Activity reflected geographic expansion and investment in manufacturing capacity aligned with defense modernization and space mobility demand. Buyers pursued greater scale, specialized engineering capabilities and supply chain consolidation.
Media and entertainment
Deal value surged 218% while volume remained flat, indicating that growth was concentrated in fewer, larger transactions. Activity focused on premium sports franchises, live entertainment venues, gaming and hospitality platforms, and scaled media assets. Buyers targeted businesses with durable brand value, recurring revenues and monetizable audiences, seeking to expand consumer reach and deepen engagement across physical and digital channels.
Oil and gas, chemicals
M&A moderated, with deal value declining 34% and volume falling 31%, reflecting selective capital deployment. Activity pointed to consolidation and vertical integration, particularly across midstream infrastructure, natural gas processing and specialty chemicals. Buyers targeted scaled assets in core basins to expand capacity and capture operating synergies.